Spherical Pellets for Cholinesterase Inhibitor Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current detection systems for cholinesterase inhibitors, particularly in the form of spherical pellets or granules, suffer from inadequate color change intensity and uniformity due to their physicochemical properties and particle size distribution, which affects their ability to accurately detect nerve agents.
Innovation Solution
Spherical pellets with immobilized cholinesterase enzymes in a porous, water-insoluble magnesium aluminometasilicate material, combined with a spheronizing agent like microcrystalline cellulose, are produced through extrusion-spheronization, ensuring a specific surface area, particle size, and enzyme loading that enhances the enzymatic hydrolysis of acetylthiocholine or butyrylthiocholine, resulting in a clear color change with redox or chromogenic indicators.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If spherical pellets with immobilized cholinesterase are used for detection, then detection sensitivity and accuracy are improved, but manufacturing precision and particle size uniformity are difficult to achieve
Solution Approach 1:
The patent optimizes specific parameters including particle size range (0.5-2.0 mm), enzyme activity (1-100 nkat.g-1), and substrate concentration to achieve both manufacturing feasibility and detection sensitivity. By controlling these parameters within specific ranges, the patent resolves the contradiction between easy manufacture and detection precision.
Solution Approach 2:
The use of porous support material with controlled porosity (30-70%) provides large surface area for enzyme immobilization while maintaining uniform particle structure. This enables consistent enzyme loading across particles, improving both manufacturing uniformity and detection sensitivity simultaneously.
2Measurement precision
If enzyme activity is increased to improve detection, then detection sensitivity improves, but enzyme stability and pellet uniformity deteriorate
Solution Approach 1:
The patent creates local optimal conditions by controlling pH (6.0-8.0) and ionic strength in the microenvironment around immobilized enzymes. This local optimization allows high enzyme activity while maintaining stability through controlled local conditions rather than requiring uniform high activity throughout.
Solution Approach 2:
The detection pellets are designed as single-use disposable units with controlled enzyme activity ranges. This approach accepts that individual enzyme molecules have limited stability but maintains system reliability through standardized replacement rather than attempting to extend individual enzyme lifetime.
3Ease of manufacture
If irregular granules are used for detection, then ease of manufacture is improved, but color change uniformity and detection accuracy worsen
Solution Approach 1:
The patent specifies spherical or near-spherical pellet shapes with diameter 0.5-2.0 mm. This geometric standardization ensures uniform surface area-to-volume ratios, consistent reagent distribution, and uniform color change during detection, while remaining compatible with simple manufacturing processes like extrusion or spheronization.
4Ease of operation
If substrate and indicator are pre-loaded in detection tube, then ease of operation is improved, but detection precision may be affected by premature reactions
Solution Approach 1:
The detection system is segmented into separate compartments: pellets with immobilized enzyme in one section, and substrate/indicator solution in another. This physical segmentation prevents premature reactions while maintaining ease of operation through simple tube design. The user simply needs to break the seal and allow natural mixing, eliminating complex操作步骤.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pellets provide a more uniform and intense color change, improving the detection sensitivity and accuracy of cholinesterase inhibitors, specifically nerve agents, by maintaining enzyme activity and stability, and facilitating easier handling and loading into detection tubes.
Implementation Method 1
enzymatic hydrolysis of substrate acetylthiocholine and/or butyrylthiocholine producing the corresponding thiol
Implementation Method 2
indicated by a color change in a redox indicator
Implementation Method 3
or by enzymatic hydrolysis of a chromogenic substrate
Implementation Method 4
immobilized enzyme based on cholinesterase in a porous, water-insoluble magnesium aluminometasilicate material
Data Source
Figure 1
AI summary
The present invention relates to the spherical pellets containing an immobilized enzyme based on cholinesterase in activity of 1 to 100 nkat.g-1, wherein the enzyme is immobilized in a porous, water insoluble inorganic material with specific surface area ranging between 200 and 400 m2.g-1, bulk density ranging between 0,05 and 0,25 g.l-1, pH of aqueous extract ranging between 6 and 8, and mean agglomerated particle size ranging between 50 and 150 µm, mixed with at least one spheronizing agent, wherein at least 75% of the resulting pellets have mean particle size between 0.1 and 3.0 mm, a manufacturing process of such pellets by extrusion-spheronization or rotogranulation, the use of such pellets for the detection of cholinesterase inhibitors, and a detection tube comprising such pellets.